| Date Filed | Type | Description |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2020 |
4
| Hau Bosun (Director) has filed a Form 4 on EXICURE, INC.|
Txns:
| Granted 21,693 options to buy
@ $2.79, valued at
$60.5k
|
|
| 01/24/2020 |
4
| Hau Bosun (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 23,458 options to buy
@ $10.19, valued at
$239k
|
|
| 08/06/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/03/2019 |
3/A
| Hau Bosun (Director) has filed a Form 3/A on BICYCLE THERAPEUTICS plc |
| 05/23/2019 |
3/A
| Hau Bosun (Director) has filed a Form 3/A on BICYCLE THERAPEUTICS Ltd |
| 05/22/2019 |
3
| Hau Bosun (Director) has filed a Form 3 on BICYCLE THERAPEUTICS Ltd |
| 01/25/2019 |
4
| Hau Bosun (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 14,500 options to buy
@ $16.19, valued at
$234.8k
|
|
| 06/08/2018 |
4
| Hau Bosun (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Bought 2,898 shares
@ $34.9399, valued at
$101.3k
|
|
| 06/05/2018 |
4
| Hau Bosun (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Bought 7,142 shares
@ $29.1895, valued at
$208.5k
|
|
| 05/22/2018 |
4
| Hau Bosun (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 4,499 options to buy
@ $19.71, valued at
$88.7k
|
|
| 04/26/2018 |
4
| Hau Bosun (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 9,086 options to buy
@ $8.01, valued at
$72.8k
|
|
| 03/13/2018 |
4
| Hau Bosun (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 285 options to buy
@ $19.35, valued at
$5.5k
|
|
| 02/13/2018 |
3
| Hau Bosun (Director) has filed a Form 3 on Cellular Biomedicine Group, Inc. |
| 02/07/2018 |
3
| Hau Bosun (Director) has filed a Form 3 on Evolus, Inc. |